Linthorst GE - Search Results

1

Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers.

Linthorst GE, Vedder AC, Aerts JM, Hollak CE. Linthorst GE, et al. Clin Chim Acta. 2005 Mar;353(1-2):201-3. doi: 10.1016/j.cccn.2004.10.019. Clin Chim Acta. 2005. PMID: 15698608

2

Blood group does not correlate with disease severity in patients with Fabry disease (alpha-galactosidase A deficiency).

Linthorst GE, Folman CC, Aerts JM, Hollak CE. Linthorst GE, et al. Blood Cells Mol Dis. 2003 Nov-Dec;31(3):324-6. doi: 10.1016/s1079-9796(03)00163-3. Blood Cells Mol Dis. 2003. PMID: 14636646

3

Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta.

Linthorst GE, Hollak CE, Donker-Koopman WE, Strijland A, Aerts JM. Linthorst GE, et al. Kidney Int. 2004 Oct;66(4):1589-95. doi: 10.1111/j.1523-1755.2004.00924.x. Kidney Int. 2004. PMID: 15458455 Free article. Clinical Trial.

4

Home treatment for Fabry disease: practice guidelines based on 3 years experience in The Netherlands.

Linthorst GE, Vedder AC, Ormel EE, Aerts JM, Hollak CE. Linthorst GE, et al. Nephrol Dial Transplant. 2006 Feb;21(2):355-60. doi: 10.1093/ndt/gfi221. Epub 2005 Oct 25. Nephrol Dial Transplant. 2006. PMID: 16249196

5

Novel therapeutic targets for the treatment of Fabry disease.

Hollak CE, Vedder AC, Linthorst GE, Aerts JM. Hollak CE, et al. Among authors: linthorst ge. Expert Opin Ther Targets. 2007 Jun;11(6):821-33. doi: 10.1517/14728222.11.6.821. Expert Opin Ther Targets. 2007. PMID: 17504019 Review.

6

Elevated globotriaosylsphingosine is a hallmark of Fabry disease.

Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ. Aerts JM, et al. Among authors: linthorst ge. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7. doi: 10.1073/pnas.0712309105. Epub 2008 Feb 19. Proc Natl Acad Sci U S A. 2008. PMID: 18287059 Free PMC article.

7

Prevalence of symptoms in female Fabry disease patients: a case-control survey.

Bouwman MG, Rombach SM, Schenk E, Sweeb A, Wijburg FA, Hollak CE, Linthorst GE. Bouwman MG, et al. Among authors: linthorst ge. J Inherit Metab Dis. 2012 Sep;35(5):891-8. doi: 10.1007/s10545-011-9447-9. Epub 2012 Mar 20. J Inherit Metab Dis. 2012. PMID: 22431073 Free PMC article.

8

Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine.

Rombach SM, van den Bogaard B, de Groot E, Groener JE, Poorthuis BJ, Linthorst GE, van den Born BJ, Hollak CE, Aerts JM. Rombach SM, et al. Among authors: linthorst ge. Hypertension. 2012 Oct;60(4):998-1005. doi: 10.1161/HYPERTENSIONAHA.112.195685. Epub 2012 Aug 6. Hypertension. 2012. PMID: 22868390

9

alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease.

Linthorst GE, Hollak CE, Korevaar JC, Van Manen JG, Aerts JM, Boeschoten EW. Linthorst GE, et al. Nephrol Dial Transplant. 2003 Aug;18(8):1581-4. doi: 10.1093/ndt/gfg194. Nephrol Dial Transplant. 2003. PMID: 12897098

10

[Fabry's disease; towards a treatment].

Linthorst GE, Hollak CE, Bosman DK, Heymans HS, Aerts JM. Linthorst GE, et al. Ned Tijdschr Geneeskd. 2000 Dec 9;144(50):2391-5. Ned Tijdschr Geneeskd. 2000. PMID: 11145093 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page